CTT Pharmaceutical Holdings, Inc. (CTTH) stock
CTTHOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2015, quarter ended Sep 30, 2015Last filing: 10-Q on Nov 18, 2026
$0.06−0.00 (-0.17%)
Close on Oct 16, 2026Market cap $1.26MP/E –Yield –
CTT Pharmaceutical operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
CTT Pharmaceutical's operating income for the twelve months ending Jun 30, 2014 was $79.95K. For fiscal 2014 it was -$672.16K. The highest annual figure on record is -$18.91K in fiscal 2013.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2014 | Dec 31, 2014 | -$672.16K | – |
| FY2013 | Dec 31, 2013 | -$18.91K | – |
| FY2012 | Dec 31, 2012 | -$1.19M | – |
| FY2011 | Dec 31, 2011 | -$757.94K | – |
| FY2010 | Dec 31, 2010 | -$2.07M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2015 | Mar 31, 2015 | -$337.05K | – |
| Q2 FY2014 | Jun 30, 2014 | -$22.32K | – |
| Q1 FY2014 | Mar 31, 2014 | -$1.67K | – |
| Q4 FY2013 | Dec 31, 2013 | $129.68K | – |
| Q3 FY2013 | Sep 30, 2013 | -$25.74K | – |
| Q2 FY2013 | Jun 30, 2013 | -$62.54K | – |
| Q1 FY2013 | Mar 31, 2013 | -$60.32K | – |
| Q4 FY2012 | Dec 31, 2012 | -$202.04K | – |
| Q3 FY2012 | Sep 30, 2012 | -$118.53K | – |
| Q2 FY2012 | Jun 30, 2012 | -$191.52K | – |
| Q1 FY2012 | Mar 31, 2012 | -$582.82K | – |
| Q4 FY2011 | Dec 31, 2011 | -$186.89K | – |
| Q3 FY2011 | Sep 30, 2011 | -$107.42K | – |
| Q2 FY2011 | Jun 30, 2011 | -$436.77K | – |
| Q1 FY2011 | Mar 31, 2011 | -$26.86K | – |
| Q4 FY2010 | Dec 31, 2010 | -$559.86K | – |
| Q3 FY2010 | Sep 30, 2010 | -$981.65K | – |
| Q2 FY2010 | Jun 30, 2010 | -$385.63K | – |
See a number that looks wrong?